The effects of dialyzer reuse on plasma antioxidative mechanisms in patients on regular hemodialysis treatment

Free Radical Biology and Medicine

Volumn 21, Issue 2, 1996, Pages 225-231

  Gündüz, Zübeyde ^a,b   Düşünsel, Ruhan ^a,b,c   Köse, Kader ^a,b   Utas, Cengiz ^a,b   Doǧan, Pakize ^a,b  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b Department of Nephrology ^*  (Turkey)

^c ERCIYES UNIVERSITY   (Turkey)

Author keywords

Ceruloplasmin; Copper; Free radicals; Hemodialysis; Hemodialyzer reuse; Myeloperoxidase; Plasma antioxidant activity; Sulphydryl groups; Transferrin

Indexed keywords

ANTIOXIDANT; CERULOPLASMIN; COPPER; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; THIOL GROUP; TRANSFERRIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COST CONTROL; ENZYME ACTIVITY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0029934263     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(96)00021-4     Document Type: Article

References (39)

1. 1. Schmidtmann, S.; Müller, M.; von Baehr, R.; Precht, K. Changes of antioxidative homeostasis in patients on chronic haemodialysis. Nephrol. Dial. Transplant. Suppl. 3:71-74; 1991.
2. 2. Halliwell, B.; Gutteridge, J. M. C. The antioxidants of human extracellular fluids. Arch. Biochem. Biophys. 280:1-8; 1990.
3. 3. Paul, J. L.; Sall, N. D.; Soni, T.; Poignet, J. L.; Lindenbaum, A.; Man, N. K.; Moatti, N.; Raichvarg, D. Lipid peroxidation abnormalities in hemodialyzed patients. Nephron 64:106-109; 1993.
4. 4. Richard, M. J.; Arnaud, J.; Jurkovitz, C.; Hachache, T.; Meftahi, H.; Laporte, F.; Foret, M.; Favier, A. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 57:10-15; 1991.
5. 5. Dasgupta, A.; Husain, S.; Ahmad, S. Increased lipid peroxidation in patients on maintenance hemodialysis. Nephron 60:56-59; 1992.
6. 6. Trznadel, K.; Pawlicki, L.; Kedziora, J.; Luciak, M.; Blaszczyk, J.; Buczynski, A. Superoxide anion generation, erythrocytes superoxide dismutase activity, and lipid peroxidation during hemoperfusion and hemodialysis in chronic uremic patients. Free Radic. Biol. Med. 6:393-397; 1989.
7. 7. Matkovics, B.; Laszlo, A.; Varga, S.I.; Gal, G.; Solymosi, T. Changes and correlations of antioxidant enzymes, lipid peroxidation and serum neutral lipids due to haemodialysis treatment in chronic uraemic patients. Int. Urol. Nephrol. 20:559-564; 1988.
8. 8. Shaldon, S. Dialyzer reuse: The time has come to stop this practice. Dial. Transplant. 22:124-126; 1993.
9. 9. Kant, K. S.; Pollak, V. E.; Cathey, M.; Goetz, D.; Berlin, R. Multiple use of dialyzers: Safety and efficacy. Kidney Int. 19:728-738; 1981.
10. 10. Heid, J.; Pauly, A. V.; Diamond, L. Survival analysis of patients undergoing dialysis. JAMA 257:645-650; 1981.
11. 11. Baris, E.; McGregor, M. The reuse of hemodialyzers: An assessment of safety and potential savings. Can. Med. Assoc. J. 148:175-204; 1993.
12. 12. Shusterman, N. H.; Feldman, H. L.; Wasserstein, A.; Strom, B.L. Reprocessing of hemodialyzers: A critical appraisal. Am. J. Kidney Dis. 15:81-91; 1989.
13. 13. Mathew, T. H.; Fazzalari, R. A.; Disney, A. P. S.; MacIntyre, D. B. Multiple use of dialyzers: An Australian view. Nephron 27:222-225; 1981.
14. 14. Ogden, D. A. Dialyzer reuse. In: Nissenson, A. R.; Fine, R. N.; Gentile, D. E. eds. Clinical dialysis. 2nd ed.. East Norwalk: Appleton de Lange; 1990:202-211.
15. 15. Pollak, V. E.; Kant, K. S.; Parnell, S. L.; Levin, N. W. Repeated use of dialyzers is safe: Long term observations on morbidity and mortality in patients with end-stage renal disease. Nephron 42:217-223; 1986.
16. 16. Sulivan, J. L.; Newton, R. B. Serum antioxidant activity in neonates. Arch. Dis. Child. 63:748-757; 1988.
17. 17. Sain, S. K. Evidence for membrane lipid peroxidation during the in vivo aging of human erythrocytes. Biochim. Biophys. Acta 937:205-210; 1988.
18. 18. Tietz, N. W. Textbook of clinical chemistry. Philadelphia: W.B. Saunders Co.; 1986:981-985.
19. 19. Sundermen, F. W.; Nomoto, S. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin. Chem. 16:903-910; 1970.
20. 20. Koster, J. F.; Biemond, P. Intracellular and extracellular sulphydryl levels in rheumatoid arthritis. Ann. Rheum. Dis. 45:44-46; 1986.
21. 21. Goto, H.; Wu, G. S.; Chen, F.; Kristeva, M.; Sevanian, A.; Rao, N. A. Lipid peroxidation in experimental uveitis: Sequential studies. Curr. Eye Res. 6:489-499; 1992.
22. 22. Markert, M.; Heierli, C.; Kuwahara, T.; Frei, J.; Wauters, J. P. Dialyzed polymorphonuclear neutrophil oxidative metabolism during dialysis: A comparative study with 5 new and reused membranes. Clin. Nephrol. 29:129-136; 1988.
23. 23. Cohen, M. S.; Elliott, D. M.; Chaplinski, T.; Pike, M. M.; Niedel, J. E. A defect in the oxidative metabolism of human polymorphonuclear leukocytes that remain in circulation early in hemodialysis. Blood 60:1283-1289; 1982.
24. 24. Hörl, W. H.; Riegel, W.; Schollmeyer, P.; Rautenberg, W.; Neumann, S. Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers. Clin. Nephrol. 25:304-307; 1986.
25. 25. Hörl, W. H.; Riegel, W.; Schollmeyer, P. Plasma levels of main granulocyte components in patients dialyzed with polycarbonate and cuprophan membranes. Nephron 45:272-276; 1987.
26. 26. Riegel, W.; Leverenz, K.; Schollmeyer, P.; Wilms, H.; Hörl, W. H. Plasma levels of main granulocyte components during hemodialysis: Effects of immunosuppression. Nephron 46:161-166; 1987.
27. 27. Höllgren, R.; Venge, P.; Danielson, B.G. Neutrophil and eosinophil degranulation during hemodialysis are mediated by the dialysis membrane. Nephron 32:329-334; 1982.
28. 28. Hörl, W. H.; Riegel, W.; Steinhauer, H. B.; Wanner, C.; Thaiss, F.; Bozkurt, F.; Haag, M.; Schollmeyer, P. Granulocyte activation during hemodialysis. Clin. Nephrol. Suppl. 26:S30-S34; 1986.
29. 29. Schulman, G.; Hakim, R. Complications of hemodialysis. In: Jacobson, H. R.; Striker, G. E.; Klahr, S. eds. The principles and practice of nephrology. Philadelphia: B.C. Decker Inc.; 1991:262.
30. 30. Trznadel, K.; Luciak, M.; Pawlicki, L.; Kedziora, J.; Blaszczyk, J.; Buczynski, A. Superoxide anion generation and lipid peroxidation processes during hemodialysis with reused cuprophan dialyzers. Free Radic. Biol. Med. 8:429-432; 1990.
31. 31. Gündüz, Z.; Utas, C.; Köse, K.; Düşünsel, R.; Doǧan, P. The effects of dialyzer reuse on lipid peroxidation in hemodialysis patients. (Abst) EDTA-ERA Congress. Vienna: April 1994:184.
32. 32. Wayner, D. D. M.; Burton, G. W.; Ingold, K. U.; Barclay, L. R. C.; Locke, S. J. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim. Biophys. Acta 924:408-419; 1987.
33. 33. Kuroda, M.; Asaka, S.; Tofuku, Y.; Takeda, R. Serum antioxidant activity in uremic patients. Nephron 41:293-298; 1985.
34. 34. Di Silvestro, R. P. Effects of inflammation on copper antioxidant enzyme levels. Adv. Exp. Med. Biol. 1156:144-150; 1989.
35. 35. Sondheimer, J. H.; Mahajan, S. K.; Rye, D. L.; Abu-Hamdan, D. K.; Migdal, S. D.; Prasad, A. S.; McDonald, F. D. Elevated plasma copper in chronic renal failure. Am. J. Clin. Nutr. 47:896-899; 1988.
36. 36. Utas, C.; Kiliç, M.; Cücer, N.; Düşünsel, R.; Saraymen, R.; Yücesoy, M.; Köse, K. Comparison of the plasma trace elements levels in patients with chronic renal failure before and after haemodialysis and healthy subjects. Gazi Med. J. 3:125-127; 1993.
37. 37. Locsey, L.; Papp, L. Study of trace elements in patients on haemodialysis. Int. Urol. Nephrol. 15:289-295; 1983.
38. 38. Bogden, J. D.; Zadzielski, E.; Weiner, B.; Oleske, J. M.; Aviv, A. Release of some trace metals from disposable coils during hemodialysis. Am. J. Clin. Nutr. 36:403-409; 1982.
39. 39. Heffner, S. E.; Repine, S. E. Pulmoner strategies of antioxidant defense. Am. Rev. Respir. Dis. 140:531-554; 1989.